Intolerance to non-steroidal anti-inflammatory drugs, including a cyclooxygenase-2-specific inhibitor;Intolérance aux anti-inflammatoires non stéroïdiens inhibiteurs spécifiques de la cyclo-oxygénase 2

Revue Francaise d'Allergologie et d'Immunologie Clinique

Volumn 43, Issue 6, 2003, Pages 393-396

  Mommens, V ^a,b   Just, N ^a   Ngo, M T ^a   Cotte, L ^a   Fournier, C ^a   Wallaert, B ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Allergy; Cyclooxygenase 2 inhibitor; Non steroidal anti inflammatory drug; Oral challenge test

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOOXYGENASE 2 INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ALLERGY; ANGIONEUROTIC EDEMA; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CASE REPORT; DRUG CROSS REACTIVITY; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; DRUG TOLERANCE; ENZYME INHIBITION; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; PROVOCATION TEST;

EID: 0141929420     PISSN: 03357457     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0335-7457(03)00198-9     Document Type: Article

References (13)

1. Woessner KM, Simon RA, Stevenson DD. The safety of celecoxib in patients with aspirin-sensitive asthma. Arthritis Rheum 2002;46:2201-6.
2. Quiralte J, Saenz de San Pedro B, Florido JJ. Safety of selective cyclooxygenase-2 inhibitor rofecoxib in patients with NSAID-induced cutaneous reactions. Ann Allergy Asthma Immunol 2002;89:63-6.
3. Martin-Garcia C, Hinojosa M, Berges P, Camacho E, Garcia-Rodriguez R, Alfaya T, et al. Safety of cyclooxygenase-2 inhibitor in patients with aspirin-sensitive Asthma. Chest 2002;123:1317-8 author reply 1318.
4. Stevenson DD, Simon RA. Lack of cross-reactivity between rofecoxib and aspirin in aspirin-sensitive patients with asthma. J Allergy Clin Immunol 2001;108:47-51.
5. Szczeklik A, Nizankowska E, Bochenek G, Nagraba K, Mejza F, Swierczynska M. Safety of a specific COX-2 inhibitor in aspirin-induced asthma. Clin Exp Allergy 2001;31:219-25.
6. Szczeklik A. Aspirin-induced asthma: new insights into pathogenesis and clinical presentation of drug intolerance. Int Arch Allergy Appl Immunol 1989;90(Suppl 1):70-5.
7. Woessner K. Crossreacting Drugs and Chemicals. Clinical Reviews in Allergy and Immunology 2003;24:149-58.
8. Dahlen B, Szczeklik A, Murray JJ. Celecoxib in patients with asthma and aspirin-intolerance. Aspirin-Intolerant Asthma Group. N Engl J Med 2001;344:142.
9. Yoshida S, Ishizaki Y, Onuma K, Shoji T, Nakagawa H, Amayasu H. Selective cyclooxygenase-2 inhibitor in patients with aspirin-induced asthma. J Allergy Clin Immunol 2000;106:1201-2.
10. Ernst EJ, Egge JA. Celecoxib-induced erythema multiforme with glyburide cross-reactivity. Pharmacotherapy 2002;22:637-40.
11. Schneider F, Meziani F, Chartier C, Alt M, Jaeger A. Fatal allergic vasculitis associated with celecoxib. Lancet 2002;359:852-3.
12. Schellenberg RR, Isserow SH, Anaphylactoid reaction to cyclooxygenase-2 inhibitor in a patient who had a reaction to a cyclooxygenase-1 inhibitor. N Engl J Med 2001;345:1856.
13. Kelkar PS, Butterfield JH, Teaford HG. Urticaria and angio-edema from cyclooxygenase-2 inhibitors. J Rheumatol 2001;28:2253-4.